News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
As Celltrion anticipates applying for US FDA approval for its Remsima biosimilar in the first half of 2014, the company this week filed suit in US District Court in Massachusetts against Janssen seeking to invalidate patents that would stop such a launch.
Cell transportation technology firm Austrianova has licensed a low-cost, disposable microfluidics platform from SIMTech to improve how it dispenses cells used in biomanufacturing and therapeutic applications.
Adaptimmune has selected Biolife’s cryopreservation media for its genetically modified T-cell receptor (TCR) product citing its ability to retain viability and potency.
Soliris manufacturer Alexion has announced its €75m ($103m) third Irish plant will create 200 new jobs.
Drugmakers are failing to make doctors and patients understand biosimilars and how to use them, which is limiting their potential, according to Amgen.